BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31689458)

  • 1. Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour.
    Tavares V; Pinto R; Assis J; Pereira D; Medeiros R
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188331. PubMed ID: 31689458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.
    Germain M; Chasman DI; de Haan H; Tang W; Lindström S; Weng LC; de Andrade M; de Visser MC; Wiggins KL; Suchon P; Saut N; Smadja DM; Le Gal G; van Hylckama Vlieg A; Di Narzo A; Hao K; Nelson CP; Rocanin-Arjo A; Folkersen L; Monajemi R; Rose LM; Brody JA; Slagboom E; Aïssi D; Gagnon F; Deleuze JF; Deloukas P; Tzourio C; Dartigues JF; Berr C; Taylor KD; Civelek M; Eriksson P; ; Psaty BM; Houwing-Duitermaat J; Goodall AH; Cambien F; Kraft P; Amouyel P; Samani NJ; Basu S; Ridker PM; Rosendaal FR; Kabrhel C; Folsom AR; Heit J; Reitsma PH; Trégouët DA; Smith NL; Morange PE
    Am J Hum Genet; 2015 Apr; 96(4):532-42. PubMed ID: 25772935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.
    Tavares V; Pinto R; Assis J; Coelho S; Brandão M; Alves S; Pereira D; Medeiros R
    Pharmacogenomics J; 2021 Apr; 21(2):222-232. PubMed ID: 33161412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
    Heit JA; Armasu SM; Asmann YW; Cunningham JM; Matsumoto ME; Petterson TM; De Andrade M
    J Thromb Haemost; 2012 Aug; 10(8):1521-31. PubMed ID: 22672568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness.
    Tavares V; Pinto R; Assis J; Pereira D; Medeiros R
    Data Brief; 2020 Jun; 30():105399. PubMed ID: 32258274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.
    Tang W; Teichert M; Chasman DI; Heit JA; Morange PE; Li G; Pankratz N; Leebeek FW; Paré G; de Andrade M; Tzourio C; Psaty BM; Basu S; Ruiter R; Rose L; Armasu SM; Lumley T; Heckbert SR; Uitterlinden AG; Lathrop M; Rice KM; Cushman M; Hofman A; Lambert JC; Glazer NL; Pankow JS; Witteman JC; Amouyel P; Bis JC; Bovill EG; Kong X; Tracy RP; Boerwinkle E; Rotter JI; Trégouët DA; Loth DW; Stricker BHC; Ridker PM; Folsom AR; Smith NL
    Genet Epidemiol; 2013 Jul; 37(5):512-521. PubMed ID: 23650146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
    Småbrekke B; Rinde LB; Evensen LH; Morelli VM; Hveem K; Gabrielsen ME; Njølstad I; Mathiesen EB; Rosendaal FR; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 Aug; 17(8):1363-1371. PubMed ID: 31124268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism risk associated with ABO, F11 and FGG loci.
    Manco L; Silva C; Fidalgo T; Martinho P; Sarmento AB; Ribeiro ML
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):528-532. PubMed ID: 29995659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.
    Rinde LB; Morelli VM; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Wilsgaard T; Smith E; Rosendaal FR; Frazer KA; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 May; 17(5):749-758. PubMed ID: 30773804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.
    Hinds DA; Buil A; Ziemek D; Martinez-Perez A; Malik R; Folkersen L; Germain M; Mälarstig A; Brown A; Soria JM; Dichgans M; Bing N; Franco-Cereceda A; Souto JC; Dermitzakis ET; Hamsten A; Worrall BB; Tung JY; ; Sabater-Lleal M
    Hum Mol Genet; 2016 May; 25(9):1867-74. PubMed ID: 26908601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F11 is associated with recurrent VTE in women. A prospective cohort study.
    Bruzelius M; Ljungqvist M; Bottai M; Bergendal A; Strawbridge RJ; Holmström M; Silveira A; Kieler H; Hamsten A; Lärfars G; Odeberg J
    Thromb Haemost; 2016 Jan; 115(2):406-14. PubMed ID: 26423325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.
    Trégouët DA; Heath S; Saut N; Biron-Andreani C; Schved JF; Pernod G; Galan P; Drouet L; Zelenika D; Juhan-Vague I; Alessi MC; Tiret L; Lathrop M; Emmerich J; Morange PE
    Blood; 2009 May; 113(21):5298-303. PubMed ID: 19278955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event.
    Skille H; Paulsen B; Hveem K; Gabrielsen ME; Brumpton B; Hindberg K; Gran OV; Rosendaal FR; Braekkan SK; Hansen JB
    J Thromb Haemost; 2020 Nov; 18(11):2861-2869. PubMed ID: 32671915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.
    Crous-Bou M; De Vivo I; Camargo CA; Varraso R; Grodstein F; Jensen MK; Kraft P; Goldhaber SZ; Lindström S; Kabrhel C
    Thromb Haemost; 2016 Sep; 116(4):705-13. PubMed ID: 27305932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.
    Johnsen HS; Bjøri E; Hindberg K; Brækkan SK; Morelli VM; Hansen JB
    Thromb Res; 2020 Jul; 191():82-89. PubMed ID: 32402998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Skille H; Paulsen B; Hveem K; Severinsen MT; Gabrielsen ME; Kristensen SR; Næss IA; Hindberg K; Tjønneland A; Brækkan SK; Hansen JB
    Thromb Res; 2021 Sep; 205():17-23. PubMed ID: 34237679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking ovarian cancer genomics: where genome-wide association studies stand?
    Pinto R; Assis J; Nogueira A; Pereira C; Pereira D; Medeiros R
    Pharmacogenomics; 2017 Nov; 18(17):1611-1625. PubMed ID: 29095100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
    Klarin D; Emdin CA; Natarajan P; Conrad MF; ; Kathiresan S
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28373160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there still room for additional common susceptibility alleles for venous thromboembolism?
    Trégouët DA; Delluc A; Roche A; Derbois C; Olaso R; Germain M; de Andrade M; Tang W; Chasman DI; van Hylckama Vlieg A; Reitsma PH; Kabrhel C; Smith N; Morange PE
    J Thromb Haemost; 2016 Sep; 14(9):1798-802. PubMed ID: 27326655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.
    Thibord F; Klarin D; Brody JA; Chen MH; Levin MG; Chasman DI; Goode EL; Hveem K; Teder-Laving M; Martinez-Perez A; Aïssi D; Daian-Bacq D; Ito K; Natarajan P; Lutsey PL; Nadkarni GN; de Vries PS; Cuellar-Partida G; Wolford BN; Pattee JW; Kooperberg C; Braekkan SK; Li-Gao R; Saut N; Sept C; Germain M; Judy RL; Wiggins KL; Ko D; O'Donnell CJ; Taylor KD; Giulianini F; De Andrade M; Nøst TH; Boland A; Empana JP; Koyama S; Gilliland T; Do R; Huffman JE; Wang X; Zhou W; Manuel Soria J; Carlos Souto J; Pankratz N; Haessler J; Hindberg K; Rosendaal FR; Turman C; Olaso R; Kember RL; Bartz TM; Lynch JA; Heckbert SR; Armasu SM; Brumpton B; Smadja DM; Jouven X; Komuro I; Clapham KR; Loos RJF; Willer CJ; Sabater-Lleal M; Pankow JS; Reiner AP; Morelli VM; Ridker PM; Vlieg AVH; Deleuze JF; Kraft P; Rader DJ; ; Min Lee K; Psaty BM; Heidi Skogholt A; Emmerich J; Suchon P; Rich SS; Vy HMT; Tang W; Jackson RD; Hansen JB; Morange PE; Kabrhel C; Trégouët DA; Damrauer SM; Johnson AD; Smith NL
    Circulation; 2022 Oct; 146(16):1225-1242. PubMed ID: 36154123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.